Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 476-481

  Neidhart, Michel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Autoantibodies; Connective tissue diseases; Cortisol; Prolactin

Indexed keywords

CYTOKINE; HYDROCORTISONE; PROLACTIN; RHEUMATOID FACTOR;

ADULT; ARTICLE; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DNA; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYDROCORTISONE; HYPERPROLACTINEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RHEUMATOID FACTOR; SIALOGLYCOPROTEINS; TETANUS TOXOID; THYROGLOBULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029876653     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Linker-Israeli M: Cytokine abnormalities in human lupus. Clin Immunol Imniunopathol 1992;63:10-2.
2. Besedovsky HO, del Ray A, Klusman I Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991;40:613-8.
3. Berczi I: Prolactin, pregnancy and autoimmune disease. J Rheumatol 1993;20:1095-100
4. Hooghe R. Delhase M, Vergani P Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoeitic system. Immunol Today 1993:14:212-4.
5. Reber PM: Prolactin and immunomodulation. Am J Med 1993;95:637-44.
6. Weiss-Carrington P: Secretory immunobiology of the mammary gland. In: Berczi I, Kovacs K, eds. Hormones and Immunity. Lancaster: MTP Press. 1987:172-202.
7. MacMurray R. Keisler D, Izui S, Walker SE: Effects of parturition, suckling, and pseudopregnancy on variable disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol 1993;20:1143-51
8. Neidhart M, Flückiger EW: Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 1992;77:449-55.
9. Palestine AG, Muellenberg-Coulombre CG, Kim MK. Bromocnptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J Clin Invest 1987;79:1078-81.
10. Riskind PN, Massacesi L, Doohttle TH, Hauser S: The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocnptine. Ann Neurol 1991;29:542-7.
11. Whyte A, Williams RO: Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988;31:927-8
12. Lavalle C. Loyo E, Paniagua R: Correlation study between proiactin and androgens in male patients with systemic lupus erythematosus J Rheumatol 1987;14:268-72.
13. Folomeev M, Prokaeva T, Nassonova V. Prolactin levels in men with SLE and RA. J Rheumatol 1991;17:1569-70.
14. Buskila D, Sukenik S, Schoenfeld Y: The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991;26:118-23
15. Jara LJ, Graef A, Lavalle C: Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991;18:349-53.
16. Jara-Quezada LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus. J Rheumatol 1992;19:1333-6.
17. Jara LJ. Silveira LH. Cuéllar ML, Pineda CJ, Scopelitis E, Espinoza LR: Hyperprolactinemia in Reiter's syndrome. J Rheumatol 1994,21:1292-7.
18. Hender LP, Bynke G: Endogenous iridoeyclitis relieved during treatment with bromocriptine. Am J Ophthalmol 1985;100:618-9.
19. Blank M, Palestine A, Nussenblatt R, Schoenfeld Y: Down regulation of autoantibody levels by cyciosporine and bromocnptine in treatment of patients with uveitis. Clin Immunol Immunopathol 1990;54.87-97
20. Pauzner R, Urowitz MB, Gladman DD, Gough JM: Prolactin in systemic lupus erythematosus. J Rheumatol 1994;21:2064-7.
21. Schauenstein K, Fassler R, Dietrich H Disturbed immune-endocrine communication in autoimmune disease. Lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis. J Immunol 1987;139:1830-3.
22. Sternberg EM, Young WS III, Bernardini R: A central nervous system defect in biosynthesis of corticotropin-reteasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1959:86:4771-5.
23. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
24. Griep EN, Boersma JW, de Kloet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993;20.469-74.
25. Tan EM, Cohen AS. Fries JR Masi AT: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1211-1.
26. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and The Committee on Prognosis Studies in SLE: Derivation of the SLEDAI, a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
27. Buchanan RRC. Wardlaw JR, Riglar AG: Antiphospholipid antibodies in the connective tissue diseases: Their relation to antiphospholipid syndrome and forme fruste disease. J Rheumatol 1989;16:757-61.
28. Gripenberg M, Walfis F, Isomaki H, Lindes E: A simple enzyme immunoassay for the demonstration of rheumatoid factor. J Immunol Methods 1979;31:109-14.
29. Stiffler-Rosenberg G, Fey H: Messung von tetanus-antitoxin mit dem enzyme-linked immunoabsorbent assay (ELISA). Schweiz. Med Wschr 1977;107:1101-4
30. Winfield JB, Faiferman I, Koffler D: Avidity of anti-DNA antibodies in serum and in IgG glomerular eluates in patients with systemic lupus erythematosus. Association of high avidity and high DNA antibody with glomerulonephritis. J Clin Invest 1977;59:90-5.